Shares of Theratechnologies jumped after the company received Food and Drug Administration approval for Egrifta WR, its treatment for excess abdominal fat in adults with HIV and lipodystrophy.

New, improved formulation set to replace EGRIFTA SV®MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or ...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Over the next 12 months, these companies will reportedly develop a new manufacturing facility in Gujarat, India.

Industry Leaders to Leverage Complementary Expertise and Industry-Leading Capabilities, Develop New Manufacturing Facility in Gujarat Region LONGUEUIL, QC and MUMBAI, India, March 25, 2025 ...

Approach could herald new way of delivering drugs beyond birth control — such as for HIV, TB, schizophrenia, chronic pain, or ...

Researchers at the Massachusetts Institute of Technology (MIT) have developed a DIY jab that could soon offer women long-term ...

For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...